Back to Browse Journals » International Journal of Nanomedicine » Volume 4

Transport characteristics of nanoparticle-based ferrofluids in a gel model of the brain

Authors Soubir Basak, David Brogan, Hans Dietrich, Rogers Ritter, et al.

Published Date April 2009 Volume 2009:4 Pages 9—26

DOI http://dx.doi.org/10.2147/IJN.S4114

Published 1 April 2009

Soubir Basak1, David Brogan2, Hans Dietrich2, Rogers Ritter3, Ralph G Dacey2, Pratim Biswas1

1Aerosol and Air Quality Research Laboratory, Department of Energy, Environmental and Chemical Engineering, Washington University in St. Louis, St. Louis, MO, USA; 2Department of Neurological Surgery, Washington University School of Medicine, St. Louis, MO, USA; 3Stereotaxis Inc., St. Louis, MO, USA

Abstract: A current advance in nanotechnology is the selective targeting of therapeutics by external magnetic field-guided delivery. This is an important area of research in medicine. The use of magnetic forces results in the formation of agglomerated structures in the field region. The transport characteristics of these agglomerated structures are explored. A nonintrusive method based on in situ light-scattering techniques is used to characterize the velocity of such particles in a magnetic field gradient. A transport model for the chain-like agglomerates is developed based on these experimental observations. The transport characteristics of magnetic nanoparticle drug carriers are then explored in gel-based simulated models of the brain. Results of such measurements demonstrate decreased diffusion of magnetic nanoparticles when placed in a high magnetic field gradient.  

Keywords: nanoparticle ferrofluid, gel-brain model, drug delivery, magnetic agglomeration, transport, magnetic fields

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Cytotoxicity of graphene oxide and graphene oxide loaded with doxorubicin on human multiple myeloma cells

Wu S, Zhao X, Cui Z, Zhao C, Wang Y, Du L, Li Y

International Journal of Nanomedicine 2014, 9:1413-1421

Published Date: 14 March 2014

Characterization of drug-release kinetics in trabecular bone from titania nanotube implants

Aw MS, Khalid KA, Gulati K, Atkins GJ, Pivonka P, Findlay DM, Losic D

International Journal of Nanomedicine 2012, 7:4883-4892

Published Date: 12 September 2012

A comparative study of three ternary complexes prepared in different mixing orders of siRNA/redox-responsive hyperbranched poly (amido amine)/hyaluronic acid

Chen CJ, Zhao ZX, Wang JC, Zhao EY, Gao LY, Zhou SF, Liu XY, Lu WL, Zhang Q

International Journal of Nanomedicine 2012, 7:3837-3849

Published Date: 18 July 2012

An MRI-visible non-viral vector for targeted Bcl-2 siRNA delivery to neuroblastoma

Shen M, Gong FM, Pang PF, Zhu KS, Meng XC, Wu C, Wang J, Shan H, Shuai XT

International Journal of Nanomedicine 2012, 7:3319-3332

Published Date: 2 July 2012

Acoustic cardiac signals analysis: a Kalman filter–based approach

Salleh SH, Hussain HS, Swee TT, Ting CM, Noor AM, Pipatsart S, Ali J, Yupapin PP

International Journal of Nanomedicine 2012, 7:2873-2881

Published Date: 11 June 2012

Novel formulation of a methotrexate derivative with a lipid nanoemulsion

Moura JA, Valduga CJ, Tavares ER, Kretzer IF, Maria DA, Maranhao RC

International Journal of Nanomedicine 2011, 6:2285-2295

Published Date: 12 October 2011

Thermal and ultrasonic influence in the formation of nanometer scale hydroxyapatite bio-ceramic

Poinern GE, Brundavanam RK, Le XT, Djordjevic S, Prokic M, Fawcett D

International Journal of Nanomedicine 2011, 6:2083-2095

Published Date: 23 September 2011

A randomized controlled trial of quetiapine for psychosis in Parkinson’s disease

Paul Shotbolt, Michael Samuel, Chris Fox, Anthony S David

Neuropsychiatric Disease and Treatment 2009, 5:327-332

Published Date: 25 May 2009